Product Program year 2024 Source: CMS Open Payments

(2809) Trilogy 100

Device Medical Device

Open in the dashboard

General payments

$181,585

55 payments

Research payments

$0

0 payments

Through program year 2024, $181,585 in general payments and $0 in research payments were reported against (2809) Trilogy 100 (Medical Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $30,513 5
2023 General $61,557 18
2022 General $88,613 11
2021 General $902 21

Breakdown

Who paid General payments · program years 2021–2024
  1. Philips Electronics North America Corporation $181,585 55 payments
Top recipients General payments · program year 2024
  1. Philip Choi Pulmonary Disease · Ann Arbor, MI $11,556 38% · 2 payments
  2. John Hansen-Flaschen Pulmonary Disease · Philadelphia, PA $9,325 31% · 1 payment
  3. Vanderbilt University Medical Center Teaching hospital · TN $9,325 31% · 1 payment
  4. Allison Tobey Otolaryngology · Pittsburgh, PA $306 1% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Pulmonary Disease Internal Medicine $20,881 99% · 2 practitioners
  2. Otolaryngology $306 1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Michigan $11,556 38% · 1 recipient
  2. Pennsylvania $9,631 32% · 2 recipients
  3. Tennessee $9,325 31% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

55 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record